
|Videos|March 16, 2022
Real-world feedback on nasal spray DED treatment
Author(s)Carly Rose, OD, FAAO
Carly Rose, OD, FAAO, shares her experience and patient feedback on implementing the first and only FDA-approved nasal spray for dry eye treatment.
Advertisement
Carly Rose, OD, FAAO, in practice at Eyecare on the Square in Cincinnati, Ohio, shares her experience implementing varenicline solution nasal spray (TYRVAYA, Oyster Point Pharma), the first and only FDA-approved nasal spray for dry eye treatment, in her practice, as well as the promising patient feedback she's received.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Retinal ganglion cells: What they can tell us and why we should listen
2
Dompé enrolls first patients in phase 3 trial of Isocyclosporin for atopic keratoconjunctivitis
3
What advancements optometrists are hoping for in 2026
4
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
5








































